(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SOZEMPA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SOZEMPA

ST13

US500000097333970

Class

5

Filing

97333970

Registration

7059516

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

05/23/2023

Trademark type

Word

Nice classes

5

Filing date

03/28/2022

Registration date

05/23/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/23/2023

Last transaction

05/23/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Glattpark-Opfikon, CH

Examiner

ATTANG, UDEME U

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Takeda Pharmaceuticals International AG

Representatives

Karl M. Zielaznicki, Esq. TROUTMAN PEPPER HAMILTON SANDERS LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for use in the field of neurosciencefor the treatment of neurological and nervous system diseases and disorders; pharmaceutical preparations for the treatment of seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/23/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/23/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/07/2023

PUBO

PUBLISHED FOR OPPOSITION

03/07/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/31/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

01/31/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/31/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

01/31/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/31/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/14/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/13/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/13/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/27/2022

GNRT

NON-FINAL ACTION E-MAILED

09/27/2022

CNRT

NON-FINAL ACTION WRITTEN

09/27/2022

DOCK

ASSIGNED TO EXAMINER

09/27/2022

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

08/24/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/01/2022

NWAP

NEW APPLICATION ENTERED

03/31/2022

Continuous trademark protection

Get notified about every new filing that threatens SOZEMPA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.